A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC

PHASE2TerminatedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 10, 2011

Primary Completion Date

November 4, 2011

Study Completion Date

December 28, 2011

Conditions
Advanced Hepatocellular Carcinoma (HCC)
Interventions
DRUG

OSI-906

OSI-906 administered orally

DRUG

Placebo

Matching placebo administered orally

Trial Locations (41)

333

Chang Gung Medical Foundation LinKou Branch, Taoyuan District

500

Changhua Christian Hospital, Changhua

807

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

1200

Cliniques Universitaires Saint-Luc, Brussells

6202

Hopital l'Archet 2, Nice

9000

Universitair Ziekenhuis Gent, Ghent

13385

Hopital de la Timone, Marseille

15706

Hospital Clinico Universitario de Santiago de Compostela, Santiago de Compostela

20122

Fondazione Ca' Granda Ospedale Maggiore Policlinico, Divisione di Gastroenterologia I, Milan

28220

Hospital Puerta de Hierro Majadahonda, Madrid

31008

Clinica Universitaria de Navarra, Pamplona

39120

Universitätsklinikum Magdeburg A.ö.R., Magdeburg

40705

Taichung Veterans General Hospital, Taichung

44805

Centre Rene Gauducheau, Saint-Herblain

45122

Universitatsklinikum Essen, Essen

52336

Medical College of Wisconsin, Milwaukee

66421

Universitatsklinikum des Saarlandes, Homburg

70112

Tulane University Health Services Center, New Orleans

75012

Hôpital Saint-Antoine, Paris

75020

Hôpital de Tenon, Paris

80123

Ospedale Fatebenefratelli, Dipartimento Medicina Interna, Napoli

80131

IRCCS Istituto Nazionale per lo studio e la cura dei tumori Fondazione G. Pascale-SSD Epatobiliare, Napoli

90095

University of California - Los Angeles, Los Angeles

90127

Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione ISMETT-Dipartimento di Epatologia e Gastroenterologia, Palermo

93143

Hopital Jean Verdier - Dervice d'Hepato-Gastroenterologie, Bondy

94010

Hôpital Henri Mondor, Créteil

97239

Oregon Health & Science University, Portland

98101

Virginia Mason Medical Center, Seattle

98109

Seattle Cancer Care Alliance University of Washington, Seattle

169608

Singapore General Hospital, Singapore

308433

Johns Hopkins Singapore International Medical Centre, Singapore

06097

Universitätsklinikum Halle, Halle

Unknown

Queen Mary Hospital, Hong Kong

China Medical University Hospital, Taichung

602-739

Pusan National University Hospital, Busan

700-721

Kyungpook National University Hospital, Daegu

410-769

National Cancer Center, Goyang-si

110-774

Seoul National University Hospital, Seoul

120-752

Severance Hospital, Seoul

135-710

Samsung Medical Center, Seoul

08036

Hospital Clinic Provincial, Barcelona

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY